ARCHIVES

NCAB Working Group Renamed, Adds Karen Antman

This article is from The Cancer Letter archive.

Vol. 20 No. 48 | December 16, 1994

Download PDF Visit The Full Archive

Related Articles

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

September 24, 2004

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 5, 1990

RG7204 Meets Endpoints Of Extending Survival, PFS

February 25, 2011

CCOP 2 Under Way After Bitter Recompetition Cancer Control Protocols Being Review; PLs, Affiliates Listed

February 19, 1988

Minority Based CCOP RFA Generate Wide Interest; 44 Letters Of Intent Received for Eight Awards

September 1, 1989

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001